TGase1 Activators belong to a class of chemical compounds that play a crucial role in the modulation of tissue transglutaminase 1 (TGase1), also known as keratinocyte transglutaminase (kTGase). TGase1 is a member of the transglutaminase enzyme family, and it is primarily expressed in the epidermal keratinocytes, which are the predominant cell type in the outermost layer of the skin, the epidermis. TGase1 is involved in a range of cellular processes, particularly in the formation of the epidermal barrier, a critical function of the skin. This enzyme catalyzes the cross-linking of proteins by forming covalent bonds between specific amino acids, a process known as protein cross-linking or transamidation. TGase1 Activators are small molecules designed to interact with TGase1, influencing its enzymatic activity and, consequently, the cross-linking of proteins within the epidermis.
The mechanism of action of TGase1 Activators typically involves binding to specific regions of the TGase1 enzyme, inducing conformational changes that may enhance or inhibit its transamidation activity. By modulating TGase1 activity, these activators impact the cross-linking of structural proteins such as keratin, filaggrin, and involucrin, which are essential for the formation of the epidermal barrier. Research into TGase1 Activators provides valuable insights into the complex regulatory mechanisms governing skin barrier function and epidermal development. Understanding how these activators interact with TGase1 contributes to our knowledge of the intricate processes involved in maintaining skin integrity and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
VE-821 is an inhibitor of the ATR kinase, which indirectly influences Nibrin activity by affecting the DNA damage response pathway. By inhibiting ATR, VE-821 can modify the response to DNA damage, potentially altering Nibrin's role in DNA repair. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
ATM Kinase Inhibitor, KU-55933, is a key player in the response to DNA double-strand breaks. By inhibiting ATM, this chemical can indirectly affect Nibrin's function in DNA repair processes. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor that influences DNA repair mechanisms. While it primarily targets PARP enzymes, its impact on DNA repair can have downstream effects on Nibrin-mediated pathways. | ||||||
LY2603618 | 911222-45-2 | sc-364526 sc-364526A | 5 mg 50 mg | $214.00 $1809.00 | ||
LY2603618 inhibits CHK1, a kinase involved in cell cycle regulation post-DNA damage. This can indirectly affect Nibrin's function in DNA repair and the cellular response to DNA breaks. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
NU7441 inhibits DNA-PK, another kinase involved in DNA repair. Its inhibition can indirectly influence Nibrin's role in the DNA damage response. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine inhibits cyclin-dependent kinases (CDKs), affecting cell cycle regulation. This can indirectly impact Nibrin's activity in the context of DNA damage and repair. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, an HSP90 inhibitor, can influence various signaling pathways, including those involving DNA repair proteins like Nibrin. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, affecting multiple cellular signaling pathways, including those related to DNA damage response, potentially influencing Nibrin activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. This can have indirect effects on DNA damage response mechanisms involving Nibrin. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, an HDAC inhibitor, can affect gene expression patterns, potentially influencing the expression and function of proteins like Nibrin in DNA repair. | ||||||